scispace - formally typeset
R

Roland E. Schmieder

Researcher at University of Erlangen-Nuremberg

Publications -  780
Citations -  85811

Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.

Papers
More filters
Journal ArticleDOI

Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial

TL;DR: Despite different changes of systemic haemodynamics between CVVH and IHD,CVVH did not improve parameters of splanchnic regional perfusion like pHi, pCO(2)i or pCO (2) gap in septic shock patients.
Journal ArticleDOI

Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses

Dean S. Picone, +49 more
TL;DR: Cuff BP has variable accuracy for measuring either brachial or aortic intra-arterial BP, and this adversely influences correct BP classification, indicating that stronger accuracy standards for BP devices may improve cardiovascular risk management.
Journal ArticleDOI

Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

TL;DR: Clinical evidence in support of RDN as an effective interventional technique in patients with resistant hypertension is conflicting; a number of observational studies and three randomized, controlled trials support both safety and efficacy of this new therapy but some smaller studies and the large, single-blind, randomized, sham-controlled symplicity HTN-3 trial failed to show superiority ofRDN when compared with medical therapy alone.
Journal ArticleDOI

Salt and Hypertension: Is Salt Dietary Reduction Worth the Effort?

TL;DR: Dietary salt intake reduction can delay or prevent the incidence of antihypertensive therapy, can facilitate blood pressure reduction in hypertensive patients receiving medical therapy, and may represent a simple cost-saving mediator to reduce cardiovascular morbidity and mortality.